Ischemia induced by transesophageal atrial pacing stress echocardiography predicts long-term mortality

Maurizio Anselmi1, Mara Pilati, Giorgio Golia

  • 1Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Verona, Italy. maurizio.anselmi@univr.it

Cardiology
|April 1, 2008
PubMed

Insights

Transesophageal atrial pacing stress echocardiography (TAPSE) effectively predicts cardiac death in patients with coronary artery disease. An abnormal TAPSE result significantly increases the risk, showing its long-term prognostic value.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Clinical Prediction

Background:

  • Pharmacologic stress echocardiography is established for cardiac death prediction.
  • Transesophageal atrial pacing stress echocardiography (TAPSE) offers a safe alternative.
  • Prognostic data for TAPSE was previously unavailable.

Purpose of the Study:

  • To evaluate the long-term predictive value of TAPSE for mortality.
  • To assess TAPSE's utility in patients with known or suspected coronary artery disease.

Main Methods:

  • 1010 TAPSE procedures were performed in 975 patients.
  • A final cohort of 857 patients with a mean follow-up of 4.5 years was analyzed.
  • Cox regression models identified predictors of cardiac death.

Main Results:

  • Abnormal TAPSE was observed in 32% of patients, correlating with higher cardiac mortality (8.9% vs 3.6%).
  • Predictors of cardiac death included age, prior revascularization, and resting/induced wall motion abnormalities.
  • Abnormal TAPSE significantly improved cardiac death prediction models.

Conclusions:

  • TAPSE is a valuable tool for predicting mortality in coronary artery disease patients.
  • TAPSE can serve as an alternative to pharmacologic stress testing for risk stratification.
Abstract

Related Concept Videos

Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...